Cardiology News and Research

Latest Cardiology News and Research

NUS researchers develop high sensitivity, low hysteresis pressure sensor

Real-time health monitoring and sensing abilities of robots require soft electronics, but a challenge of using such materials lie in their reliability.

2 Nov 2020

How COVID death counts become the stuff of conspiracy theories

In the waning days of the campaign, President Donald Trump complained repeatedly about how the United States tracks the number of people who have died from COVID-19, claiming, "This country and its reporting systems are just not doing it right."

2 Nov 2020

Study identifies new cause of COVID-19 blood clots

Blood clots continue to wreak havoc for patients with severe COVID-19 infection, and a new study explains what may spark them in up to half of patients.

2 Nov 2020

More than 45,000 cardiac procedures were missed due to Covid-19 lockdown

The Covid-19 lockdown led to more than 45,000 cardiac procedures being missed this year, which could have a long-term impact on mortality rates as healthcare providers work to catch up.

2 Nov 2020

New model aims to predict risk of cardiovascular disease in people with type 2 diabetes

Researchers from the University of Sydney’s School of Project Management within the Faculty of Engineering have developed a model which aims to predict the risk of people living with type 2 diabetes developing cardiovascular disease.

2 Nov 2020

Study finds irritated skin as strongest predictor of hospital-acquired pressure injury

Nursing assessments of patients' skin conditions may seem routine, but an analysis of more than 5,000 patient records underscores the importance of treating and monitoring irritated skin early and eliminating the cause as an important step to prevent pressure injuries.

2 Nov 2020

People who experience high blood pressure while sleeping have increased risk of heart attacks, strokes

People who experience high blood pressure while sleeping are more likely to experience future cardiovascular disease especially heart failure, even when their daytime blood pressure is within normal ranges, according to new research published today in the American Heart Association's flagship journal Circulation.

2 Nov 2020

Researchers develop a unique method of identifying early signs of acute kidney injury

Researchers at the University of Liverpool have identified a unique method of identifying the early signs of a potentially serious condition known as Acute Kidney Injury (AKI).

2 Nov 2020

Drug used to control blood pressure may improve cancer patients’ response to immunotherapy

The same biochemical triggers that spur a "fight or flight" response when we encounter threats may help tumor cells to thrive.

30 Oct 2020

SARS-CoV-2 virus may target red marrow and prevent the formation of new erythrocytes

Specialists from the Department of Fundamental Medicine of Far Eastern Federal University (FEFU) with Russian and Japanese colleagues have probed into mechanisms of COVID-19 inside-the-body distribution linked to erythrocytes damaging.

30 Oct 2020

High Throughput Identification and Quantification of Breast Cancer With NMR-Based Metabolomics

Breast cancer is the leading cause of cancer-related death among the female population globally, despite the ever-growing technology of early detection.

From Bruker BioSpin - NMR, EPR and Imaging 30 Oct 2020

Children with multiple islet autoantibodies are more likely to progress to type 1 diabetes

Children with multiple islet autoantibodies - biological markers of autoimmunity -- are more likely to progress to symptomatic type 1 diabetes (T1D) than those who remain positive for a single autoantibody.

30 Oct 2020

Study examines link between SARS-CoV-2 genomic load and COVID-19 patient outcomes

A new study published online in the Annals of the American Thoracic Society examines whether the amount of RNA, or genomic load, of SARS-CoV-2 detected in swab tests of patients being admitted to the hospital with viral pneumonia is associated with more severe COVID-19.

30 Oct 2020

SARS-CoV-2 spike proteins can directly impact the blood-brain barrier

Like a key, SARS-CoV-2 - the virus that causes coronavirus disease 2019 (COVID-19) - attaches to specific molecules on the host cell surface, opening gateways into the cell interior.

30 Oct 2020

Study shows statins can have adverse effects on certain organs

600,000 Danes take medicine containing statins. Statins lower the cholesterol level and thus helps prevent cardiovascular disease and blood clots.

30 Oct 2020

Study: Toxins produced by tube-dwelling anemones have pharmacological potential

Researchers based in Brazil and the United States have completed the first-ever mapping exercise to profile the toxins produced by tube-dwelling anemones, or cerianthids, a family of marine animals belonging to the same phylum (Cnidaria) as sea anemones, jellyfish and corals.

30 Oct 2020

RNI researchers to study the impact of excessive speeds on the human brain, body

Before the first Virgin Hyperloop ride takes off, the brains behind pioneering neuroscience research at West Virginia University will help ensure the health and well-being of its passengers and operators.

30 Oct 2020

COVID-19-related myocarditis may be a relatively rare occurrence, indicates study

A study conducted by Richard Vander Heide, MD, PhD, Professor and Director of Pathology Research at LSU Health New Orleans School of Medicine, and Marc Halushka, MD, PhD, Professor of Pathology at Johns Hopkins University School of Medicine, suggests myocarditis caused by COVID-19 may be a relatively rare occurrence.

30 Oct 2020

Symptoms and outcomes of 3.32 million people tested for SARS-CoV-2

A recent study published on the preprint server medRxiv* in October 2020 shows the need for large-scale studies on the clinical characteristics and outcomes of COVID-19 at the national and international scale. This is essential to shape interventions and optimize the use of resources to contain and manage a second wave of the pandemic.

30 Oct 2020

MD65 IgG-YTE shows powerful post-exposure neutralization of SARS-CoV-2

A recent study published in the preprint server bioRxiv in October 2020 describes a reliable animal model to demonstrate the powerful capacity of human neutralizing mAbs directed against SARS-CoV-2 to prevent viral binding the host cell receptor and thus block infection. This indicates the lifesaving value of mAbs in severe COVID-19.

29 Oct 2020

Cardiology News and Research

Latest Cardiology News and Research

NUS researchers develop high sensitivity, low hysteresis pressure sensor

How COVID death counts become the stuff of conspiracy theories

Study identifies new cause of COVID-19 blood clots

More than 45,000 cardiac procedures were missed due to Covid-19 lockdown

New model aims to predict risk of cardiovascular disease in people with type 2 diabetes

Study finds irritated skin as strongest predictor of hospital-acquired pressure injury

People who experience high blood pressure while sleeping have increased risk of heart attacks, strokes

Researchers develop a unique method of identifying early signs of acute kidney injury

Drug used to control blood pressure may improve cancer patients’ response to immunotherapy

SARS-CoV-2 virus may target red marrow and prevent the formation of new erythrocytes

High Throughput Identification and Quantification of Breast Cancer With NMR-Based Metabolomics

Children with multiple islet autoantibodies are more likely to progress to type 1 diabetes

Study examines link between SARS-CoV-2 genomic load and COVID-19 patient outcomes

SARS-CoV-2 spike proteins can directly impact the blood-brain barrier

Study shows statins can have adverse effects on certain organs

Study: Toxins produced by tube-dwelling anemones have pharmacological potential

RNI researchers to study the impact of excessive speeds on the human brain, body

COVID-19-related myocarditis may be a relatively rare occurrence, indicates study

Symptoms and outcomes of 3.32 million people tested for SARS-CoV-2

MD65 IgG-YTE shows powerful post-exposure neutralization of SARS-CoV-2

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cardiology News and Research

Latest Cardiology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in